Literature DB >> 11243520

The effect of cardiopulmonary lymphatic obstruction on heart and lung function.

Y Cui1, J D Urschel, N J Petrelli.   

Abstract

Many thoracic surgical procedures involve excision or destruction of intrathoracic and mediastinal lymphatics. It is widely assumed that the mediastinal lymphatic system is surgically expendable, and that destruction of mediastinal lymphatics has no significant adverse physiological effect. Cardiac lymphatic obstruction may give rise to cardiac lymphedema and impaired cardiac function. Similarly, obstruction of pulmonary lymphatics may result in pulmonary perivascular lymphedema, endothelial injury, and pulmonary artery hypertension. This review summarizes the possible deleterious effects of intrathoracic lymphatic destruction and the benefits of pharmacological and surgical enhancement of active lymph drainage.

Entities:  

Mesh:

Year:  2001        PMID: 11243520     DOI: 10.1055/s-2001-9917

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  7 in total

Review 1.  Delivery of gene and cellular therapies for heart disease.

Authors:  Justin A Mariani; David M Kaye
Journal:  J Cardiovasc Transl Res       Date:  2010-05-11       Impact factor: 4.132

2.  Sphingosine 1-phosphate receptor 1 regulates the directional migration of lymphatic endothelial cells in response to fluid shear stress.

Authors:  Vinay N Surya; Eleftheria Michalaki; Eva Y Huang; Gerald G Fuller; Alexander R Dunn
Journal:  J R Soc Interface       Date:  2016-12       Impact factor: 4.118

Review 3.  Cardiac metastases.

Authors:  R Bussani; F De-Giorgio; A Abbate; F Silvestri
Journal:  J Clin Pathol       Date:  2006-11-10       Impact factor: 3.411

4.  Lymphangiogenic therapy prevents cardiac dysfunction by ameliorating inflammation and hypertension.

Authors:  LouJin Song; Xian Chen; Terri A Swanson; Brianna LaViolette; Jincheng Pang; Teresa Cunio; Michael W Nagle; Shoh Asano; Katherine Hales; Arun Shipstone; Hanna Sobon; Sabra D Al-Harthy; Youngwook Ahn; Steven Kreuser; Andrew Robertson; Casey Ritenour; Frank Voigt; Magalie Boucher; Furong Sun; William C Sessa; Rachel J Roth Flach
Journal:  Elife       Date:  2020-11-17       Impact factor: 8.140

5.  A Theranostic Cellulose Nanocrystal-Based Drug Delivery System with Enhanced Retention in Pulmonary Metastasis of Melanoma.

Authors:  Surachet Imlimthan; You Cheng Khng; Outi Keinänen; Wenzhong Zhang; Anu J Airaksinen; Mauri A Kostiainen; Brian M Zeglis; Hélder A Santos; Mirkka Sarparanta
Journal:  Small       Date:  2021-03-18       Impact factor: 13.281

6.  Lung adenocarcinoma with repetitive endotracheal/endobronchial metastasis 20 years after surgery: A case report.

Authors:  Yohei Maki; Yoshifumi Kimizuka; Hisashi Sasaki; Takayuki Yamamoto; Chie Watanabe; Tomoya Sano; Yoichi Tagami; Kazuhisa Misawa; Jun Miyata; Yuji Fujikura; Hideyuki Shimazaki; Akihiko Kawana
Journal:  Thorac Cancer       Date:  2020-11-14       Impact factor: 3.500

7.  M2b macrophages stimulate lymphangiogenesis to reduce myocardial fibrosis after myocardial ischaemia/reperfusion injury.

Authors:  Cuiping Wang; Yuan Yue; Suiqing Huang; Keke Wang; Xiao Yang; Jiantao Chen; Jiaxing Huang; Zhongkai Wu
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.